MENU
SLNO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Soleno Therapeutics (SLNO) Ownership - Who owns Soleno Therapeutics?

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases... Show more

Profile

Industry
Medical Specialties
Address
203 Redwood Shores Parkway
Phone
+1 650 213-8444
Employees
42
Web
https://www.soleno.life

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.38B
P/E Ratio
N/A
Total Cash
291.44M
Projected Growth
N/A
Total Debt
52.83M
Revenue
N/A
Risk (Beta)
-3.42
Dividend Yield
N/A
Total Cash/Share
6.36
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

SLNO
Capitalization
3.38B
P/E Ratio
N/A
Risk (Beta)
-3.42
Dividend Yield
N/A
Total Cash
291M
Total Cash/Share
6.36
Total Debt
52.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
245M
P/B Ratio
13.77
Cash Flow
N/A
Earnings
-4.38
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
46K
Current Ratio
15.68
Current Revenue Per Employee
50.00
Dividends Per Share - Security
N/A
EBITDA
-173.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
-4100.00
Revenue To Assets
-68.74
Shares Held By Institutions
3.13B
Shares Outstanding - Current
45.9M
Total Liabilities
85.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
63.893
View a ticker or compare two or three
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of medical diagnostics and therapeutics based on its proprietary technology for precision metering of gas flow

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
203 Redwood Shores Parkway
Phone
+1 650 213-8444
Employees
42
Web
https://www.soleno.life